|
Comparative Oncology Trials Consortium (COTC)
In an effort to establish the organizational infrastructure to undertake translational clinical trials in companion animals, the CCR’s COP has formed the Comparative Oncology Trial Consortium (COTC). This new drug development consortium is based on collaborative relationships with accredited schools of veterinary medicine. The COTC will initiate trials in collaboration with NCI investigators, academic institutions, and the pharmaceutical industry. These trials will be implemented through the collective caseloads of the COTC membership institutions with trial design, oversight, data management, and assessment of biological endpoints organized by the CCR-COP. These trials will be small in scale and will emphasize the assessment of biological questions related to drug development. The design of these trials will answer essential questions emerging from the development plans of agents destined for human patients.
All veterinary universities that met the established criteria have been invited to join the Comparative Oncology Trial Consortium.
Auburn University
Colorado State University
Cornell University
North Carolina State University
Purdue University
The Ohio State University
Tufts University
University of California at Davis
University of Florida
University of Georgia
University of Illinois
University of Michigan
University of Missouri
University of Pennsylvania
University of Tennessee
University of Wisconsin
For more information regarding the Comparative Oncology Trial Consortium, please contact Christina Mazcko at mazckoc@mail.nih.gov
|
